Confirming you are not from the U.S. or the Philippines

By giving this statement, I explicitly declare and confirm that:
  • I am not a U.S. citizen or resident
  • I am not a resident of the Philippines
  • I do not directly or indirectly own more than 10% of shares/voting rights/interest of the U.S. residents and/or do not control U.S. citizens or residents by other means
  • I am not under the direct or indirect ownership of more than 10% of shares/voting rights/interest and/or under the control of U.S. citizen or resident exercised by other means
  • I am not affiliated with U.S. citizens or residents in terms of Section 1504(a) of FATCA
  • I am aware of my liability for making a false declaration.
For the purposes of this statement, all U.S. dependent countries and territories are equalled to the main territory of the USA. I accept full responsibility for the accuracy of this declaration and commit to personally address and resolve any claims or issues that may arise from a breach of this statement.
Cancel Confirm
We are dedicated to your privacy and the security of your personal information. We only collect emails to provide special offers and important information about our products and services. By submitting your email address, you agree to receive such letters from us. If you want to unsubscribe or have any questions or concerns, write to our Customer Support.
Confirm
Octa trading broker Sign up Log in
Octa trading broker
Open trading account
Trading news
Back
21 Dec 2020

Biontech CEO: Vaccine works with the new British mutation

Biontech CEO says he is confident that the vaccine works with the new British mutation and he will investigate the mutation in the coming days. 

The comments follow earlier news reported that existing vaccines will be able to fight infection from new Covid variants.

Vin Gupta of the Institute for Health Metrics and Evaluation said emerging strains are likely to be genetically similar to prior ones.

The optimism in comments follows the UK on Saturday announcing that it identified a new mutation of the virus that can spread more quickly.

Background on vaccine approval

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced on Monday that the European Commission (EC) had granted a conditional marketing authorization (CMA) to Pfizer and BioNTech for COMIRNATY® (also known as BNT162b2), for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 16 years of age and older.

This follows the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) positive opinion to authorize the vaccine.

The EC granted this CMA in the interest of public health to help address the COVID-19 pandemic. The CMA is valid in all 27 member states of the European Union (EU).

Market implications

There were fears and risk-off to start the week which sent oil prices plummeting and US stocks over the edge, along with GBP while the US dollar picked up a safe haven bid. 

WTI plunge

S&P 500 tanks

The move followed a bearish engulfing and spinning top. 

Dec 21, 2020

UK PM Johnson said to make ‘last-ditch push’ for Brexit deal with move on fish

UK PM Johnson is said to make ‘last-ditch push’ for Brexit deal with move on fish, which is potential support for GBP crosses with markets in wait and
Read more Previous
Dec 21, 2020

EUR/GBP Price Analysis: Bears take back control, eyes on 0.9031 POC

The point of control, POC, of the daily downside correction and breakout is located at 0.9031. Bears have taken the cross to challenge bullish commitm
Read more Next